Schedule 13G ownership disclosure

AKERO THERAPEUTICS INC

Security class unavailable · CUSIP: 00973Y108

Event date: 2019-06-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,104,858
Percent of class
14.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-039416
Form type
SC 13G
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
Jul 05, 2019
Reporting period
Jun 24, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub